High DNMT1 expression is especially prevalent in high-grade tumors, tamoxifen-resistant cancers, and TNBC subtypes, and it is linked to shorter overall survival (OS) and disease-free survival (DFS). This evidence concerns the gene DNMT1 and cancer.